Menu
Back to Journals » International Journal of Nanomedicine » Volume 12
Original Research
A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,636 | Dovepress* | 8,539+ | 1,452 | 9,991 | |
| PubMed Central* | 1,097 | 359 | 1,456 | ||
| Totals | 9,636 | 1,811 | 11,447 | ||
| *Since 20 March 2017 | |||||
View citations on PubMed Central and Google Scholar